Novo Holdings Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 74
Professionals
  • Investments
  • 433
  • Portfolio
  • 117
  • Exits
  • 168
Exits

Novo Holdings General Information

Description

Founded in 1999, Novo Holdings is a venture capital investment firm based in Hellerup, Denmark. The firm prefers to invest in the life sciences, oncology, digital health sectors.

Contact Information

Formerly Known As
Nova A/S
Year Founded
1999
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Tuborg Havnevej 19
  • 2900 Hellerup
  • Denmark
+45 35 00 00 00

Novo Holdings Investments (433)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
IO Biotech 13-Jan-2021 Later Stage VC 00000 Drug Discovery Clinical Trials - Phase 3 0000000000 0000000000 00.0
0000000 06-Jan-2021 00000 00000 000.00 Surgical Devices Generating Revenue 0000000000 0000000000 00.0
00000000 15-Dec-2020 00000 00000 000.00 Biotechnology Clinical Trials - Phase 2 0000000000 0000000000 00.0
0000000000 10-Dec-2020 0000000000 Other Pharmaceuticals and Biotechnology Profitable
000000 0000 10-Dec-2020 00000 00000 00000 Decision/Risk Analysis Generating Revenue 000000 00000000
00000 000000000000 09-Dec-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 0000000 00000000 00.0
00000000 000000000 08-Dec-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 0000000 00000000 00.0
00000000 00000000 03-Dec-2020 0000000000 Enterprise Systems (Healthcare) Generating Revenue
Den Jyske Sparekasse 26-Nov-2020 Buyout/LBO 00000 National Banks Profitable
MycoWorks 17-Nov-2020 Later Stage VC 0000 Synthetic Textiles Generating Revenue
You’re viewing 10 of 433 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novo Holdings Exits (167)

Company Name Exit Date Exit Type Exit Size
F-Star Therapeutics 22-Nov-2020 Reverse Merger
0000000 29-Oct-2020 000 0000
000000 00000000000 16-Oct-2020 000 00000
000000 16-Oct-2020 000 00000
000000 00000000000 09-Oct-2020 000 0000
000000 00000000000 09-Sep-2020 000 00 00000000
0000000 0000000000 19-Aug-2020 000 00000
000000000 00000000 07-Aug-2020 000 0000
Freeline 07-Aug-2020 IPO 00000
Inozyme Pharma 24-Jul-2020 IPO 00000
You’re viewing 10 of 167 exits. Get the full list »

Novo Holdings Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Novo Holdings Team (131)

Name Title Deals Funds Boards Office
Kasim Kutay Chief Executive Officer 0 0 San Francisco, CA
Peter Haahr Chief Financial Officer 0 Hellerup, Denmark
Christoffer Søderberg Managing Partner and Head of Principal Investments 0 0 Hellerup, Denmark
Morten Beck Jørgensen Managing Partner, Financial Investments 0 0 Hellerup, Denmark
Søren Moller Ph.D Managing Partner, Novo Seeds 0 0 0 Hellerup, Denmark
You’re viewing 5 of 131 team members. Get the full list »

Novo Holdings Co-Investors (286)

Name With Exits Lead Partner Series Industry
Vivo Capital 9 0 0 Series chart Industry bar
New Enterprise Associates 0 00 Series chart Industry bar
OrbiMed 0 00 Series chart Industry bar
Rock Springs Capital 0 0 Series chart Industry bar
venBio 0 00 Series chart Industry bar
You’re viewing 5 of 286 co-investors. Get the full list »